Medicare Enrolled
Dr. Philip Cassar, M.D.
Internal Medicine · Garden City, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cassar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cassar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cassar
Dr. Philip Cassar is an internal medicine specialist in Garden City, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cassar performed 5,346 Medicare services across 3,433 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cassar received a total of $2,237 from 38 pharmaceutical and/or device companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cassar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in NY
$2,237 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,346
Medicare services
Top 5% in NY for internal medicine
3,433
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~281 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,954 | $72 | $382 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
1,187 | $158 | $877 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,101 | $109 | $598 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
309 | $118 | $546 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
86 | $197 | $1,902 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
79 | $100 | $5,750 |
| Endoscopic insertion of stomach tube A flexible endoscope is used to guide the placement of a tube into the stomach. |
71 | $191 | $2,164 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $155 | $898 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
60 | $215 | $2,830 |
| Endoscopic control of upper GI bleeding A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine. |
47 | $182 | $2,320 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
35 | $176 | $4,269 |
| Radiologist review of bile duct tube placement imaging A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope. |
30 | $21 | $384 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
27 | $344 | $4,957 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
27 | $46 | $268 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $120 | $870 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
22 | $8 | $46 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
22 | $46 | $3,555 |
| Endoscopic control of bleeding in large intestine A flexible tube with a camera is inserted into the large intestine to locate and stop bleeding. |
22 | $241 | $2,366 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
22 | $99 | $781 |
| Pancreatic or bile duct stent insertion A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open. |
21 | $429 | $4,962 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
21 | $390 | $4,795 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
16 | $327 | $4,004 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $165 | $701 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
15 | $109 | $1,008 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $78 | $450 |
| Emergency department visit, low level of medical decision making An emergency department visit for a patient requiring a low level of medical decision making. |
14 | $67 | $594 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
13 | $27 | $3,748 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
12 | $99 | $6,693 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $49 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
3.7% medium
95.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,237
Total received (2018-2024)
Avg $320/year across 7 years
Top 26% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,237 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$843
2023
$394
2022
$159
2021
$80
2020
$61
2019
$328
2018
$373
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$128
Janssen Biotech, Inc.
$113
Boston Scientific Corporation
$108
Lilly USA, LLC
$67
GENZYME CORPORATION
$55
Regeneron Healthcare Solutions, Inc.
$45
IRONWOOD PHARMACEUTICALS, INC
$43
Takeda Pharmaceuticals U.S.A., Inc.
$43
Braintree Laboratories, Inc.
$35
Lexicon Pharmaceuticals, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Mallinckrodt Hospital Products Inc.
$24
Merck Sharp & Dohme LLC
$24
Novo Nordisk Inc
$23
RedHill Biopharma Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Phathom Pharmaceuticals, Inc.
$20
CapsoVision, Inc.
$17
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$230
Boston Scientific Corporation
$205
GENZYME CORPORATION
$161
ABBVIE INC.
$148
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$128
Takeda Pharmaceuticals U.S.A., Inc.
$124
Ironwood Pharmaceuticals, Inc
$103
Novo Nordisk Inc
$102
AbbVie, Inc.
$80
BOSTON SCIENTIFIC CORPORATION
$80
Regeneron Healthcare Solutions, Inc.
$68
Lilly USA, LLC
$67
IRONWOOD PHARMACEUTICALS, INC
$60
Shionogi Inc
$59
Intercept Pharmaceuticals, Inc.
$54
Ardelyx, Inc.
$45
Merck Sharp & Dohme Corporation
$38
Merck Sharp & Dohme LLC
$37
Braintree Laboratories, Inc.
$35
Daiichi Sankyo Inc.
$33
Vifor Pharma, Inc.
$30
E.R. Squibb & Sons, L.L.C.
$29
Lexicon Pharmaceuticals, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
AbbVie Inc.
$25
Mallinckrodt Hospital Products Inc.
$24
RedHill Biopharma Inc.
$21
INTERCEPT PHARMACEUTICALS, INC.
$20
Ferring Pharmaceuticals Inc.
$20
Phathom Pharmaceuticals, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
Concordia Pharmaceuticals Inc.
$19
PFIZER INC.
$18
CapsoVision, Inc.
$17
Allergan Inc.
$16
UCB, Inc.
$16
Celgene Corporation
$15
Allergan, Inc.
$15
Top 3 companies account for 26.6% of all-time payments
Associated products mentioned in payments ›
APRISO · Agile Esophageal · Biliary Stent Introducer · CLENPIQ · CREON · CapsoCam Plus · Cimzia · Compliance EndoKit · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · ELIQUIS · ENTYVIO · EXALT Model D · General - Metal Stents - G.I. · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · JARDIANCE · LINZESS · Linzess · MOVANTIK · Mavyret · Motegrity · Mulpleta · OCALIVA · OMVOH · OrcaPod · REMICADE · RESOLUTION CLIP · RINVOQ · Resolution Clip · SKYRIZI · SPYGLASS · STELARA · SUTAB · Symproic · TERLIVAZ · TREMFYA · TRULANCE · Talicia · VIBERZI · VOQUEZNA · Veltassa · Wegovy · XIFAXAN · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
9,762
Per 100K population
703.2
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cassar is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cassar experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Cassar performed 1,954 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cassar receive payments from pharmaceutical companies?
Yes. Dr. Cassar received a total of $2,237 from 38 companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cassar's costs compare to other internal medicine physicians in Garden City?
Dr. Cassar's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cassar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Garden City
Browse internal medicine physicians in Garden City ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology